Graves Light Lenhart Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$208K Buy
+308
New +$183K 0.02% 187
2024
Q4
– Sell
-328
Closed -$203K – 191
2024
Q3
$203K Buy
+328
New +$194K 0.03% 181
2022
Q3
– Sell
-304
Closed -$165K – 555
2022
Q2
$165K Hold
304
– – 0.03% 183
2022
Q1
$180K Sell
304
-194
-39% -$111K 0.03% 186
2021
Q4
$332K Hold
498
– – 0.05% 142
2021
Q3
$285K Hold
498
– – 0.05% 145
2021
Q2
$251K Sell
498
-36
-7% -$17K 0.04% 156
2021
Q1
$244K Buy
534
+7
+1% +$3.34K 0.04% 162
2020
Q4
$245K Sell
527
-27
-5% -$12.7K 0.05% 151
2020
Q3
$245K Sell
554
-27
-5% -$11.2K 0.05% 136
2020
Q2
$211K Buy
+581
New +$195K 0.05% 145

Other funds holding TMO

Graves Light Lenhart Wealth's TMO Position: Q3 2026 in Review

Graves Light Lenhart Wealth opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 308 shares worth $208K. The stake represents 0.02% of the portfolio and ranks #187 among its holdings. This is a return to the name: Graves Light Lenhart Wealth previously reported a position in TMO as recently as Q3 2024.

Graves Light Lenhart Wealth first reported a position in TMO in Q2 2020 and has held it in 11 quarters since. The position peaked at $332K in Q4 2021. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Graves Light Lenhart Wealth held 308 shares of Thermo Fisher Scientific worth $208K as of Q3 2026.
  • Thermo Fisher Scientific was a new Graves Light Lenhart Wealth position in Q3 2026.
  • Thermo Fisher Scientific made up 0.02% of Graves Light Lenhart Wealth's portfolio in Q3 2026, its #187 holding.
  • Graves Light Lenhart Wealth first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 11 quarters since.
  • Graves Light Lenhart Wealth's Thermo Fisher Scientific position peaked at $332K in Q4 2021.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Graves Light Lenhart Wealth's 13F filing for Q3 2026, filed 9 Oct 2026.